Brian Savage, Interim Chief Legal Officer at Teva Pharmaceutical Industries, sold TEVA on Sep 18, 2026
Data as of Oct 16
▼ SELL$174K4,503 shares at $38.69Brian Savage Interim Chief Legal OfficerTEVA Teva Pharmaceutical Industries Ltd
- Traded
- Sep 18, 2026
- Disclosed
- Sep 22, 2026
- Filed
- 4 days after the trade
Form 4s are due within two business days.
Official filing (SEC Form 4) ↗
The price around the disclosure
TEVA since disclosure
+5.0%
after the sale
Similar stocks (XLV) since disclosure
+4.0%
XLV — its sector index fund
Change in closing price from Sep 22, 2026 (the first trading day on or after disclosure) to Oct 16, 2026. Dividends excluded. Not a return anyone earned.
Our take
None of our tested rules fired on this trade.
Other trades in the same filing
- ▼ SELLBrian Savage Interim Chief Legal OfficerTEVA Teva Pharmaceutical Industries Ltd$12.2Kdisclosed Sep 22 · filed 4 days after the trade
- ▼ SELLBrian Savage Interim Chief Legal OfficerTEVA Teva Pharmaceutical Industries Ltd$98.8Kdisclosed Sep 22 · filed 4 days after the trade